LONG-TERM IMMUNOGENICITY AND EFFICACY OF RECOMBINANT ChAdOx1 nCoV- 19 CORONA VIRUS VACCINE (COVISHIELD) IN PATIENTS ON HEMODIALYSIS – A PROSPECTIVE, 1-YEAR FOLLOW-UP COHORT STUDY

https://storage.unitedwebnetwork.com/files/1099/9924f6e840f4a525a6b7022396ba4904.pdf
LONG-TERM IMMUNOGENICITY AND EFFICACY OF RECOMBINANT ChAdOx1 nCoV- 19 CORONA VIRUS VACCINE (COVISHIELD) IN PATIENTS ON HEMODIALYSIS – A PROSPECTIVE, 1-YEAR FOLLOW-UP COHORT STUDY
Aarthi
Muthukumaran
Jayalakshmi Seshadri vetrikuzhal@gmail.com Madras Medical College and Rajiv Gandhi Government General Hospital Institute of Nephrology Chennai
Raman Swaminathan crrt.onco@gmail.com Madras Cancer Care Foundation and Apollo Speciality Hospital Medical Oncology Chennai
Mallika Ravindran drmallikaravindran@gmail.com Anderson Diagnostics and Services Private Limited Biochemistry Chennai